HIGHFDA DRUG

Unichem Pharmaceuticals USA Cyclobenzaprine Recall for Label Mix-Up Affects 230 Bottles (2025)

FDA enforcement lists 230 bottles of Cyclobenzaprine labeled incorrectly as Meloxicam. The labeling error was detected in a nationwide recall. Health professionals and patients should stop using the mislabeled bottles immediately. Contact Unichem Pharmaceuticals USA or a clinician for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
August 27, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 27, 2025
Hazard Level
HIGH
Brands
CYCLOBENZAPRINE HYDROCHLORIDE, Unichem Pharmaceuticals USA, Inc.
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PETS

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
CYCLOBENZAPRINE HYDROCHLORIDE, Unichem Pharmaceuticals USA, Inc.
Product type
Cyclobenzaprine Hydrochloride Tablets USP 10 mg
Model numbers
Lot No GMML24026A, Expires 09/30/2027
UPC codes
29300-413, 29300-414, 29300-415, 29300-413-05, 29300-413-10, 29300-413-01, 29300-413-19, 29300-414-01 +5 more
Colors
blue, yellow
Sizes
90-count bottles, 10 mg
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 27, 2025

  2. Reported by FDA DRUG

    September 24, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Unichem Pharmaceuticals USA Inc. or your healthcare provider for guidance. Notification method: Press Release

About This Product

Cyclobenzaprine is a muscle relaxant prescribed for short-term relief of muscle spasms. Labels must correctly identify the active ingredient.

Why This Is Dangerous

The label mix-up could lead to incorrect medication administration, potential adverse drug reactions, and reduced therapeutic efficacy.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

The immediate impact is confusion and potential harm if the wrong drug is taken. No injuries reported yet.

Practical Guidance

How to identify if yours is affected

  1. Check bottle label for Cyclobenzaprine vs Meloxicam
  2. Check Lot GMML24026A and expiration 09/30/2027

Where to find product info

FDA recall page and Unichem Pharmaceuticals USA, Inc. communications

What timeline to expect

Refund or replacement timelines will be provided by recall notices; typically several weeks

If the manufacturer is unresponsive

  • Document all communications with the company
  • Contact FDA consumer hotline if needed
  • File a complaint with state board of pharmacy if necessary

How to prevent similar issues

  • Always verify drug name and indication before dispensing
  • Use barcode scanning when available
  • Cross-check labels during packaging

Documentation advice

Keep bottle, packaging, and recall notices; note lot and expiration date

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Cyclobenzaprine Hydrochloride Tablets USP, 10 mg, 90-count bottle. Manufacturer: Unichem Laboratories Ltd, India. Manufactured for: Unichem Pharmaceuticals USA, Inc., East Brunswick, NJ. NDC 29300-415-19. Quantity: 230 bottles. Lot: GMML24026A. Expiration: 09/30/2027. Distribution: Nationwide in the USA.

Reported Incidents

No injuries or incidents have been reported in the recall notice.

Key Facts

  • Lot GMML24026A
  • Label mix-up between Cyclobenzaprine 10 mg and Meloxicam 7.5 mg

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPETS
Injury Types
POISONINGOTHER

Product Details

Model Numbers
Lot No GMML24026A
Expires 09/30/2027
UPC Codes
29300-413
29300-414
29300-415
+10 more
Affected States
ALL
Report Date
September 24, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more